MRSA and VRE strains kill C. elegans using traits that contribute to the pathogenesis of infection in mammals, and this model system can be used to study host-pathogen interactions involving staphylococcal and enterococcal virulence factors. Importantly, Staphylococcus aureus virulence determinants involved in mammalian pathogenesis, including the quorum-sensing global virulence regulatory system agr, the global virulence regulator sarA, and the alternative sigma factor sigma(B) are required for full pathogenicity in nematodes. Based on these observations, we developed a C. elegans-S. aureus screening assay that is performed using the 384-well plate format. This whole animal assay can be used to screen compound libraries, allowing the identification of compounds that prevent host killing that would not be detected in traditional in vitro screens. Our objective is to implement this C. elegans-based assay and utilize automated, high-throughput, whole animal screens to identify compounds with efficacy against MRSA, VRE and VRSA. Identified compounds will be evaluated by carrying out dose-response and time-course studies, determining in vitro MICs, determining toxicity, and by prioritizing the compounds for testing in mammals. We also propose to characterize the compounds previously identified in a C. elegans - E. faecalis screen, and synergize with other Subprojects in order to study compounds identified through the C. elegans assays and characterize compounds from other Subrojects. The C. elegans-based assays are particularly appealing in that they allow concurrent evaluation of toxicity and antimicrobial activity, as well as study of bacterial cells that are in a non-planktonic form. Thus false leads can be eliminated from further consideration early, and new leads will be clearly identified. In addition to compounds that have direct antibacterial activity, the C. elegans-based assays will identify compounds that affect bacterial virulence factors and host function, providing new leads, but also new chemical biology tools for exploring host/pathogen interaction.

Public Health Relevance

There is an imperative need to identify new classes of antibacterials. MRSA and VRE infection, and the recent spread of vancomycin resistance to MRSA resulting in VRSA infection, are leading healthcare concerns. However, the rate of new antibiotic discovery is unlikely to meet the expected need for the foreseeable future. This project takes new approaches for antimicrobial drug discovery.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Massachusetts Eye and Ear Infirmary
United States
Zip Code
Lee, Wonsik; Do, Truc; Zhang, Ge et al. (2018) Antibiotic Combinations That Enable One-Step, Targeted Mutagenesis of Chromosomal Genes. ACS Infect Dis 4:1007-1018
Zhai, Hualei; Bispo, Paulo J M; Kobashi, Hidenaga et al. (2018) Resolution of fluoroquinolone-resistant Escherichia coli keratitis with a PROSE device for enhanced targeted antibiotic delivery. Am J Ophthalmol Case Rep 12:73-75
Yuen, Grace J; Ausubel, Frederick M (2018) Both live and dead Enterococci activate Caenorhabditis elegans host defense via immune and stress pathways. Virulence 9:683-699
Wurster, Jenna I; Bispo, Paulo J M; Van Tyne, Daria et al. (2018) Staphylococcus aureus from ocular and otolaryngology infections are frequently resistant to clinically important antibiotics and are associated with lineages of community and hospital origins. PLoS One 13:e0208518
Keohane, Colleen E; Steele, Andrew D; Fetzer, Christian et al. (2018) Promysalin Elicits Species-Selective Inhibition of Pseudomonas aeruginosa by Targeting Succinate Dehydrogenase. J Am Chem Soc 140:1774-1782
Majed, Hiwa; Johnston, Tatiana; Kelso, Celine et al. (2018) Structure-activity relationships of pyrazole-4-carbodithioates as antibacterials against methicillin-resistant Staphylococcus aureus. Bioorg Med Chem Lett 28:3526-3528
Slatko, Barton E; Gardner, Andrew F; Ausubel, Frederick M (2018) Overview of Next-Generation Sequencing Technologies. Curr Protoc Mol Biol 122:e59
Tiwari, Kiran B; Gatto, Craig; Walker, Suzanne et al. (2018) Exposure of Staphylococcus aureus to Targocil Blocks Translocation of the Major Autolysin Atl across the Membrane, Resulting in a Significant Decrease in Autolysis. Antimicrob Agents Chemother 62:
Zhang, Sicai; Lebreton, Francois; Mansfield, Michael J et al. (2018) Identification of a Botulinum Neurotoxin-like Toxin in a Commensal Strain of Enterococcus faecium. Cell Host Microbe 23:169-176.e6
Santiago, Marina; Lee, Wonsik; Fayad, Antoine Abou et al. (2018) Genome-wide mutant profiling predicts the mechanism of a Lipid II binding antibiotic. Nat Chem Biol 14:601-608

Showing the most recent 10 out of 145 publications